H. Athanassiou

665 total citations
8 papers, 512 citations indexed

About

H. Athanassiou is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, H. Athanassiou has authored 8 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Genetics. Recurrent topics in H. Athanassiou's work include Effects of Radiation Exposure (4 papers), Glioma Diagnosis and Treatment (3 papers) and Brain Metastases and Treatment (3 papers). H. Athanassiou is often cited by papers focused on Effects of Radiation Exposure (4 papers), Glioma Diagnosis and Treatment (3 papers) and Brain Metastases and Treatment (3 papers). H. Athanassiou collaborates with scholars based in Greece, Romania and United States. H. Athanassiou's co-authors include M. Synodinou, P. Karageorgis, D. Antonadou, K. Beroukas, Despina Misailidou, Konstantinos Markou, Anna Kalogera‐Fountzila, E. Samantas, Angelos Nikolaou and Tudor–Eliade Ciuleanu and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

H. Athanassiou

8 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Athanassiou Greece 4 229 201 184 179 132 8 512
J Skołyszewski Poland 12 172 0.8× 126 0.6× 148 0.8× 52 0.3× 154 1.2× 59 433
A.G. Taghian United States 10 149 0.7× 73 0.4× 137 0.7× 52 0.3× 209 1.6× 20 488
Simon G. Tang Taiwan 12 162 0.7× 211 1.0× 379 2.1× 50 0.3× 192 1.5× 18 797
Su-Mi Chung South Korea 11 85 0.4× 110 0.5× 124 0.7× 60 0.3× 124 0.9× 15 399
De‐Xing Qin China 8 218 1.0× 274 1.4× 231 1.3× 72 0.4× 229 1.7× 16 506
Haruo Inokuchi Japan 14 240 1.0× 128 0.6× 125 0.7× 28 0.2× 149 1.1× 39 483
Yoshiomi Hatayama Japan 14 323 1.4× 73 0.4× 126 0.7× 40 0.2× 128 1.0× 41 553
Sandra Röddiger Germany 11 226 1.0× 72 0.4× 130 0.7× 37 0.2× 68 0.5× 14 471
C. van Herpen Netherlands 12 177 0.8× 375 1.9× 325 1.8× 47 0.3× 315 2.4× 28 669
Avraham Eisbruch United States 10 273 1.2× 331 1.6× 254 1.4× 22 0.1× 182 1.4× 13 665

Countries citing papers authored by H. Athanassiou

Since Specialization
Citations

This map shows the geographic impact of H. Athanassiou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Athanassiou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Athanassiou more than expected).

Fields of papers citing papers by H. Athanassiou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Athanassiou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Athanassiou. The network helps show where H. Athanassiou may publish in the future.

Co-authorship network of co-authors of H. Athanassiou

This figure shows the co-authorship network connecting the top 25 collaborators of H. Athanassiou. A scholar is included among the top collaborators of H. Athanassiou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Athanassiou. H. Athanassiou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
2.
Athanassiou, H., M. Synodinou, Despina Misailidou, et al.. (2005). Randomized Phase II Study of Temozolomide and Radiotherapy Compared With Radiotherapy Alone in Newly Diagnosed Glioblastoma Multiforme. Journal of Clinical Oncology. 23(10). 2372–2377. 212 indexed citations
3.
Athanassiou, H., M. Synodinou, M. Paraskevaidis, et al.. (2004). Combination of temozolomide (TMZ) and radiotherapy (RT) versus radiotherapy (RT) alone in newly diagnosed glioblastoma multiforme (GBM): A randomized phase II study. International Journal of Radiation Oncology*Biology*Physics. 60(1). S162–S163. 2 indexed citations
4.
Antonadou, D., H. Athanassiou, M. Synodinou, et al.. (2004). Final results of a randomized phase III trial of chemoradiation treatment + amifostine in patients with colorectal cancer: Clinical radiation oncology hellenic group. International Journal of Radiation Oncology*Biology*Physics. 60(1). S140–S141. 3 indexed citations
5.
Athanassiou, H., D. Antonadou, N. Coliarakis, et al.. (2003). Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: Results of a randomized trial. International Journal of Radiation Oncology*Biology*Physics. 56(4). 1154–1160. 79 indexed citations
6.
Antonadou, D., H. Athanassiou, George E. Sarris, et al.. (2003). 1087 Randomized phase III trial of chemoradiation treatment amifostine in patients with colorectal cancer. European Journal of Cancer Supplements. 1(5). S325–S325. 1 indexed citations
7.
Athanassiou, H., M. Synodinou, M. Paraskevaidis, et al.. (2003). 311 Temozolomide (TMZ) combined with radiotherapy (RT) versus radiotherapy (RT) alone in newly diagnosed glioblastoma multiforme (GBM): A randomized phase III study. European Journal of Cancer Supplements. 1(5). S95–S96. 2 indexed citations
8.
Antonadou, D., N. Coliarakis, M. Synodinou, et al.. (1999). 18 Randomized phase III trial of radiation ± amifostine in patients with advanced stage lung cancer. International Journal of Radiation Oncology*Biology*Physics. 45(3). 154–154. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Skołyszewski Breakdown of academic impact, for papers by A.G. Taghian Breakdown of academic impact, for papers by Simon G. Tang Breakdown of academic impact, for papers by Su-Mi Chung Breakdown of academic impact, for papers by De‐Xing Qin Breakdown of academic impact, for papers by Haruo Inokuchi Breakdown of academic impact, for papers by Yoshiomi Hatayama Breakdown of academic impact, for papers by Sandra Röddiger Breakdown of academic impact, for papers by C. van Herpen Breakdown of academic impact, for papers by Avraham Eisbruch
Rankless by CCL
2026